Skip to main content

Removal of skin tags: scissor excision versus non-ablative 532nm-LBO-laser in a randomized intraindividual controlled observer-blinded clinical trial : Laser is not always better.

Archives of dermatological research2025-05-11PubMed
Total: 79.5Innovation: 7Impact: 0Rigor: 0Citation: 0

Summary

In a randomized intraindividual, observer-blinded trial of 68 patients (1,257 lesions), scissor snip excision achieved higher complete healing at 12 weeks (85% vs 71%), lower pain, and greater patient preference than a non-ablative 532 nm LBO laser. Although laser treatment was faster and bloodless, it had more erythema and pigmentary changes, supporting scissor excision as first-line therapy for skin tags.

Key Findings

  • Complete healing at 12 weeks: 85% (scissor) vs 71% (532 nm LBO laser), p=0.00001
  • Lower pain scores with scissor excision (mean 2.6) vs laser (mean 3.42)
  • Patient preference favored scissor excision (63% vs 19% for laser; 18% indifferent)
  • Laser was ~39% faster but had higher rates of erythema and hyper/hypopigmentation

Clinical Implications

Prefer scissor snip excision as first-line for pedunculated fibromas; counsel patients that lasers may be faster but carry higher risk of erythema and pigment changes and do not improve healing.

Why It Matters

This RCT provides high-quality evidence that challenges the assumption that lasers are superior for skin tag removal and supports a simpler, lower-cost approach.

Limitations

  • Single-center study with short follow-up (12 weeks)
  • Limited to neck/axilla skin tags and a single non-ablative 532 nm LBO laser modality

Future Directions

Head-to-head trials with other laser modalities and longer-term outcomes (pigmentary/scar durability), cost-effectiveness analyses, and evaluation in diverse anatomical sites and skin phototypes.

Study Information

Study Type
RCT
Research Domain
Treatment
Evidence Level
I - Randomized, observer-blinded, intraindividual controlled clinical trial
Study Design
OTHER